SantosD.O., CalasansH.C.M., MarquesM. de O., PradoA.B.L.F., CarvalhoA.L.M.F. de, SantosA.E.O. dos, JesusY.H.A. de, MeloB.S., SantanaK.L. and AndradeJ.P.F. 2025. Use of Brexucabtagene Autoleucel in the treatment of Relapsed/refractory Mantle Cell Lymphoma. Electronic Journal Collection Health. 25, 6 (Jun. 2025), e20837. DOI:https://doi.org/10.25248/reas.e20837.2025.